
Peter D. Le
Examiner (ID: 14873, Phone: (571)270-5382 , Office: P/2488 )
| Most Active Art Unit | 2488 |
| Art Unit(s) | 2488 |
| Total Applications | 777 |
| Issued Applications | 611 |
| Pending Applications | 73 |
| Abandoned Applications | 123 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9068106
[patent_doc_number] => 20130259862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'ANTIBODY-MEDIATED TRANSDUCTION OF HEAT SHOCK PROTEINS INTO LIVING CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/844818
[patent_app_country] => US
[patent_app_date] => 2013-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 76
[patent_figures_cnt] => 76
[patent_no_of_words] => 7479
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13844818
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/844818 | ANTIBODY-MEDIATED TRANSDUCTION OF HEAT SHOCK PROTEINS INTO LIVING CELLS | Mar 15, 2013 | Abandoned |
Array
(
[id] => 9383357
[patent_doc_number] => 20140086838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'IDENTIFICATION OF A NEW MOLECULAR FACTOR FOR EARLY DIAGNOSIS OF UROTHELIAL CARCINOMA OF THE BLADDER'
[patent_app_type] => utility
[patent_app_number] => 14/115259
[patent_app_country] => US
[patent_app_date] => 2012-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5646
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14115259
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/115259 | IDENTIFICATION OF A NEW MOLECULAR FACTOR FOR EARLY DIAGNOSIS OF UROTHELIAL CARCINOMA OF THE BLADDER | May 1, 2012 | Abandoned |
Array
(
[id] => 6389845
[patent_doc_number] => 20100317834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'IgG Immunoglobulin Variants with Optimized Effector Function'
[patent_app_type] => utility
[patent_app_number] => 12/862583
[patent_app_country] => US
[patent_app_date] => 2010-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 67887
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317834.pdf
[firstpage_image] =>[orig_patent_app_number] => 12862583
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/862583 | IgG Immunoglobulin Variants with Optimized Effector Function | Aug 23, 2010 | Abandoned |
Array
(
[id] => 6062026
[patent_doc_number] => 20110200552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'CYTOKINE DESIGN'
[patent_app_type] => utility
[patent_app_number] => 12/744069
[patent_app_country] => US
[patent_app_date] => 2008-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 17534
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20110200552.pdf
[firstpage_image] =>[orig_patent_app_number] => 12744069
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/744069 | CYTOKINE DESIGN | Nov 20, 2008 | Abandoned |
Array
(
[id] => 6534580
[patent_doc_number] => 20100204100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'BIOLOGICAL AGENTS ACTIVE IN CENTRAL NERVOUS SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 12/596330
[patent_app_country] => US
[patent_app_date] => 2008-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11616
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204100.pdf
[firstpage_image] =>[orig_patent_app_number] => 12596330
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/596330 | BIOLOGICAL AGENTS ACTIVE IN CENTRAL NERVOUS SYSTEM | Apr 16, 2008 | Abandoned |
Array
(
[id] => 6440551
[patent_doc_number] => 20100104502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ENDOTHELIAL DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 12/513826
[patent_app_country] => US
[patent_app_date] => 2007-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 32021
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20100104502.pdf
[firstpage_image] =>[orig_patent_app_number] => 12513826
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/513826 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ENDOTHELIAL DYSFUNCTION | Nov 5, 2007 | Abandoned |
Array
(
[id] => 5010400
[patent_doc_number] => 20070280879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Therapeutic Use Of Rm1 Antigen'
[patent_app_type] => utility
[patent_app_number] => 10/592401
[patent_app_country] => US
[patent_app_date] => 2005-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15659
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20070280879.pdf
[firstpage_image] =>[orig_patent_app_number] => 10592401
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/592401 | Therapeutic Use Of Rm1 Antigen | Mar 10, 2005 | Abandoned |
| 95/000037 | LARGE ANIMAL MODEL OF INVASIVE PULMONARY ASPERGILLOSIS IN AN IMMUNOCOMPROMISED HOST | Feb 24, 2004 | Issued |
Array
(
[id] => 7004608
[patent_doc_number] => 20050169921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Method of treating hemolytic disease'
[patent_app_type] => utility
[patent_app_number] => 10/771552
[patent_app_country] => US
[patent_app_date] => 2004-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8734
[patent_no_of_claims] => 171
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20050169921.pdf
[firstpage_image] =>[orig_patent_app_number] => 10771552
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/771552 | Method of treating hemolytic disease | Feb 2, 2004 | Abandoned |
Array
(
[id] => 706729
[patent_doc_number] => 07060268
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-13
[patent_title] => 'Protein formulation'
[patent_app_type] => utility
[patent_app_number] => 10/428728
[patent_app_country] => US
[patent_app_date] => 2003-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 19
[patent_no_of_words] => 17420
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/060/07060268.pdf
[firstpage_image] =>[orig_patent_app_number] => 10428728
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/428728 | Protein formulation | May 1, 2003 | Issued |
Array
(
[id] => 6721327
[patent_doc_number] => 20030055017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Growth hormone releasing hormone expression system and methods of use, including use in animals'
[patent_app_type] => new
[patent_app_number] => 10/124759
[patent_app_country] => US
[patent_app_date] => 2002-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 23816
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20030055017.pdf
[firstpage_image] =>[orig_patent_app_number] => 10124759
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/124759 | Growth hormone releasing hormone expression system and methods of use, including use in animals | Apr 15, 2002 | Abandoned |
Array
(
[id] => 6688884
[patent_doc_number] => 20030032609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Methods of modulating of angiogenesis'
[patent_app_type] => new
[patent_app_number] => 10/121235
[patent_app_country] => US
[patent_app_date] => 2002-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12014
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032609.pdf
[firstpage_image] =>[orig_patent_app_number] => 10121235
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/121235 | Methods of modulating of angiogenesis | Apr 11, 2002 | Abandoned |
| 09/980372 | Spliceosome protein and its use | Apr 3, 2002 | Abandoned |
Array
(
[id] => 6870121
[patent_doc_number] => 20030082810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Methods for generating insulin-secreting cells suitable for transplantation'
[patent_app_type] => new
[patent_app_number] => 10/090011
[patent_app_country] => US
[patent_app_date] => 2002-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17121
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082810.pdf
[firstpage_image] =>[orig_patent_app_number] => 10090011
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/090011 | Methods for generating insulin-secreting cells suitable for transplantation | Feb 25, 2002 | Abandoned |
Array
(
[id] => 6774198
[patent_doc_number] => 20030017536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Novel polypeptide'
[patent_app_type] => new
[patent_app_number] => 10/055106
[patent_app_country] => US
[patent_app_date] => 2002-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3569
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017536.pdf
[firstpage_image] =>[orig_patent_app_number] => 10055106
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/055106 | Novel polypeptide | Jan 22, 2002 | Abandoned |
Array
(
[id] => 6661232
[patent_doc_number] => 20030135876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Maintenance of genetic lines using cryopreserved sperm'
[patent_app_type] => new
[patent_app_number] => 10/051956
[patent_app_country] => US
[patent_app_date] => 2002-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6877
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20030135876.pdf
[firstpage_image] =>[orig_patent_app_number] => 10051956
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/051956 | Maintenance of genetic lines using cryopreserved sperm | Jan 15, 2002 | Abandoned |
Array
(
[id] => 6720827
[patent_doc_number] => 20030054515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Protein-protein interactions'
[patent_app_type] => new
[patent_app_number] => 10/024595
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12113
[patent_no_of_claims] => 160
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20030054515.pdf
[firstpage_image] =>[orig_patent_app_number] => 10024595
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/024595 | Protein-protein interactions | Dec 20, 2001 | Abandoned |
Array
(
[id] => 6016928
[patent_doc_number] => 20020103155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Vectors for the expression of FGF-5 in human cells and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/023592
[patent_app_country] => US
[patent_app_date] => 2001-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6712
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103155.pdf
[firstpage_image] =>[orig_patent_app_number] => 10023592
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/023592 | Vectors for the expression of FGF-5 in human cells and uses thereof | Dec 16, 2001 | Abandoned |
Array
(
[id] => 6381121
[patent_doc_number] => 20020119929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Can1 and its role in mammalian infertility'
[patent_app_type] => new
[patent_app_number] => 10/003806
[patent_app_country] => US
[patent_app_date] => 2001-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 24822
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119929.pdf
[firstpage_image] =>[orig_patent_app_number] => 10003806
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/003806 | Can1 and its role in mammalian infertility | Nov 1, 2001 | Abandoned |
| 09/913279 | Screening method with the use of mouse suffering from neuropilin 1 gene function disruption | Oct 28, 2001 | Abandoned |